- United States
- /
- Biotech
- /
- NasdaqGS:STTK
Tyler Brous Is The Lead Independent Director of Shattuck Labs, Inc. (NASDAQ:STTK) And They Just Picked Up 3.6% More Shares
Even if it's not a huge purchase, we think it was good to see that Tyler Brous, the Lead Independent Director of Shattuck Labs, Inc. (NASDAQ:STTK) recently shelled out US$56k to buy stock, at US$7.00 per share. Although the purchase is not a big one, increasing their shareholding by only 3.6%, it can be interpreted as a good sign.
See our latest analysis for Shattuck Labs
Shattuck Labs Insider Transactions Over The Last Year
Notably, that recent purchase by Tyler Brous is the biggest insider purchase of Shattuck Labs shares that we've seen in the last year. That means that even when the share price was higher than US$6.91 (the recent price), an insider wanted to purchase shares. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. In our view, the price an insider pays for shares is very important. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. The only individual insider to buy over the last year was Tyler Brous.
You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).
Insider Ownership
Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Shattuck Labs insiders own about US$54m worth of shares. That equates to 18% of the company. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.
So What Does This Data Suggest About Shattuck Labs Insiders?
The recent insider purchase is heartening. We also take confidence from the longer term picture of insider transactions. But we don't feel the same about the fact the company is making losses. Insiders likely see value in Shattuck Labs shares, given these transactions (along with notable insider ownership of the company). In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Shattuck Labs. Case in point: We've spotted 4 warning signs for Shattuck Labs you should be aware of, and 1 of them can't be ignored.
But note: Shattuck Labs may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGS:STTK
Shattuck Labs
A biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases.
Medium-low with excellent balance sheet.
Similar Companies
Market Insights
Community Narratives


